Arcutis Biotherapeutics, Inc. Banner Image

Arcutis Biotherapeutics, Inc.

  • Ticker ARQT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arcutis Biotherapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Westlake Village, California
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets toMore solve persistent treatment challenges in serious diseases of the skin. Arcutis’ robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company’s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.
4.8 / 5.0 (164)

Arcutis Biotherapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 164 reviews.

Arcutis Biotherapeutics, Inc.

Most Recent Annual Report

Arcutis Biotherapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Arcutis Biotherapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!